Key Role for Clumping Factor B in Staphylococcus aureus Nasal Colonization of Humans

Background Staphylococcus aureus permanently colonizes the vestibulum nasi of one-fifth of the human population, which is a risk factor for autoinfection. The precise mechanisms whereby S. aureus colonizes the nose are still unknown. The staphylococcal cell-wall protein clumping factor B (ClfB) promotes adhesion to squamous epithelial cells in vitro and might be a physiologically relevant colonization factor. Methods and Findings We define the role of the staphylococcal cytokeratin-binding protein ClfB in the colonization process by artificial inoculation of human volunteers with a wild-type strain and its single locus ClfB knock-out mutant. The wild-type strain adhered to immobilized recombinant human cytokeratin 10 (CK10) in a dose-dependent manner, whereas the ClfB− mutant did not. The wild-type strain, when grown to the stationary phase in a poor growth medium, adhered better to CK10, than when the same strain was grown in a nutrient-rich environment. Nasal cultures show that the mutant strain is eliminated from the nares significantly faster than the wild-type strain, with a median of 3 ± 1 d versus 7 ± 4 d (p = 0.006). Furthermore, the wild-type strain was still present in the nares of 3/16 volunteers at the end of follow-up, and the mutant strain was not. Conclusions The human colonization model, in combination with in vitro data, shows that the ClfB protein is a major determinant of nasal-persistent S. aureus carriage and is a candidate target molecule for decolonization strategies.

[1]  M. Höök,et al.  MSCRAMM-mediated adherence of microorganisms to host tissues. , 1994, Annual review of microbiology.

[2]  H Stammer,et al.  Nasal Carriage as a Source of Staphylococcus aureus Bacteremia , 2001 .

[3]  B. Neumeister,et al.  Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections , 2004, Nature Medicine.

[4]  H. Wertheim,et al.  Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers , 2004, The Lancet.

[5]  A. van Belkum,et al.  Human Factor in Staphylococcus aureus Nasal Carriage , 2004, Infection and Immunity.

[6]  G. Sensabaugh,et al.  Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity. , 2005, The Journal of infectious diseases.

[7]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[8]  T. Foster,et al.  Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization , 2002, Cellular microbiology.

[9]  Rainer Schmidt,et al.  The cornified envelope: a model of cell death in the skin , 2005, Nature Reviews Molecular Cell Biology.

[10]  C. Wolz,et al.  Adherence of Staphylococcus aureus to Endothelial Cells: Influence of Capsular Polysaccharide, Global Regulatoragr, and Bacterial Growth Phase , 2000, Infection and Immunity.

[11]  T. Foster,et al.  Loss of Clumping Factor B Fibrinogen Binding Activity byStaphylococcus aureus Involves Cessation of Transcription, Shedding and Cleavage by Metalloprotease* , 2001, The Journal of Biological Chemistry.

[12]  L. Visai,et al.  A Monoclonal Antibody Enhances Ligand Binding of Fibronectin MSCRAMM (Adhesin) from Streptococcus dysgalactiae(*) , 1996, The Journal of Biological Chemistry.

[13]  S. Foster,et al.  IsdA of Staphylococcus aureus is a broad spectrum, iron‐regulated adhesin , 2004, Molecular microbiology.

[14]  T. Foster,et al.  Analysis of mutations in the Staphylococcus aureus clfB promoter leading to increased expression. , 2003, Microbiology.

[15]  Roberta B Carey,et al.  Methicillin-resistant S. aureus infections among patients in the emergency department. , 2006, The New England journal of medicine.

[16]  K. B. Kiser,et al.  Development and Characterization of aStaphylococcus aureus Nasal Colonization Model in Mice , 1999, Infection and Immunity.

[17]  A. van Belkum,et al.  Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Alex van Belkum,et al.  The role of nasal carriage in Staphylococcus aureus infections. , 2005, The Lancet. Infectious diseases.

[19]  S. Engelmann,et al.  ςB Activity Depends on RsbU inStaphylococcus aureus , 2001, Journal of bacteriology.

[20]  B. Kocsis,et al.  Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients , 2005, Clinical Diagnostic Laboratory Immunology.

[21]  A. Hofman,et al.  Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule". , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  A. van Belkum,et al.  Host- and Tissue-Specific Pathogenic Traits of Staphylococcus aureus , 2005, Journal of bacteriology.

[23]  J. Bartlett Mupirocin prophylaxis against nosocomial staphylococcus aureus infections in nonsurgical patients: A randomized study , 2004 .

[24]  S. Shorte,et al.  Bacterial and Host Factors Implicated in Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Mice , 2005, Infection and Immunity.

[25]  T. Foster,et al.  Clumping Factor B, a Fibrinogen-binding MSCRAMM (Microbial Surface Components Recognizing Adhesive Matrix Molecules) Adhesin of Staphylococcus aureus, Also Binds to the Tail Region of Type I Cytokeratin 10* , 2004, Journal of Biological Chemistry.

[26]  T. Foster,et al.  Immunization with Staphylococcus aureus Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model , 2006, Infection and Immunity.

[27]  A. van Belkum,et al.  Attachment of Staphylococcus aureus to eukaryotic cells and experimental pitfalls in staphylococcal adherence assays: a critical appraisal. , 2002, Journal of microbiological methods.

[28]  S. Foster,et al.  σB Modulates Virulence Determinant Expression and Stress Resistance: Characterization of a Functional rsbU Strain Derived from Staphylococcus aureus 8325-4 , 2002, Journal of bacteriology.

[29]  M. Moorhouse,et al.  Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. , 2004, The Journal of clinical investigation.

[30]  R. Novick Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. , 1967, Virology.

[31]  Gina Pugliese,et al.  Nasal Carriage as a Source of Staphylococcus aureus Bacteremia , 2001, Infection Control & Hospital Epidemiology.

[32]  R. Wenzel,et al.  Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. , 2002, The New England journal of medicine.